Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Look if this was just a dilution purely on the public only I would be worried. It will add more RXII shares to the float as many have pointed out many times. But why is nobody looking at the positive?

"We will enter into securities purchase agreements directly with certain institutional investors which will purchase not less than $100,000 of units in this offering. We will not enter into any securities purchase agreement with investors which will purchase less than $100,000 of units in this offering and such investors which purchase less than $100,000 shall rely solely on this prospectus in connection with the purchase of securities in this offering. The Placement Agent may retain one or more sub-agents or selected dealers in connection with the offering."

That says it all these big institutions are buying huge stakes of RXII that establishes a few things:

1. Big institutions hold shares long term that means all 25 mil shares just released will be held long term

2. After the offering it is more likely than not we will see who the big institutions are that bought shares, and if they are big that itself will move the share price higher depending who they are.

3. Money problem is now solved for two years till the end of 2017 and Tang Capital has converted all preferred shares that mean a rebound is in order.

4. We have the IND filing for retinal scarring of macular degeneration mid 2015. That should take place by June/July 2015

5. Other pre-clinical programs are ongoing we may see pre-clinical results in macular degeneration, Tyrosinase, and collagenese.

6. They may reveal what indications they chose for Tyrosinase and collagenase

7. Samcyprone results may come in 2015

8. Any other potential catalyst as well